jain.com

Up to $250m net funding requirement during 2025

Company: IREN

Subject kind
financing
Statement date
2025-05-13
Promised by
2025-12-31
Promised amount
250000000.0 USD
Current status
outcome unconfirmed

What the later record shows

Outcome not yet confirmed

The passages show large financings (ATM proceeds and $2.3bn of convertible notes) but give no figure for the 2025 net funding requirement for the stated projects, so the forecast cannot be checked.

Checked October 15, 2026 against filings, releases and reporting published after the claim was made. Quotes are verbatim from the linked documents.

The claim, verbatim

IREN expects a net funding requirement of up to $250m during 2025 to fund expansion to 50 EH/s, completion of Horizon 1, and Sweetwater substation and development work.

Source (primary)

iren 8-K exhibit (q3fy25presentationvf.htm) (SEC EDGAR (8-K Ex), press_release)
View cached copy (2026-10-15)Live source ↗

Quote: “Up to $250m expected net funding requirement during 2025”

How we checked this

Checked on October 16, 2026. The cited source supports every part of this claim.

The capex and funding slide lists an up to $250m expected net funding requirement during 2025 for exactly these three uses.

Confirmed in the source:

What we did: Read our cached copy of SEC EDGAR (8-K Ex) (https://www.sec.gov/Archives/edgar/data/1878848/000187884825000043/q3fy25presentationvf.htm) in full (46,276 characters, retrieved October 15, 2026) and checked each assertion in the claim against it.

Additional evidence

confirms iren 8-K exhibit (q3fy25presentationvf.htm)

Quote: “Up to $250m expected net funding requirement during 2025”

View cached copy (2026-10-15)Live source ↗

Record of changes

October 15, 2026 — stated
Automated extraction from the cited source. Recorded automatically from the cited source when it was published, then queued for evidence review.
October 15, 2026 — outcome unconfirmed
Automated extraction from the cited source. Recorded automatically from the cited source when it was published, then queued for evidence review.